Viewing Study NCT06374459

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-05-31 @ 10:35 PM
Study NCT ID: NCT06374459
Status: RECRUITING
Last Update Posted: 2025-07-18
First Post: 2024-04-10
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Sponsor: Washington University School of Medicine
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Zunsemetinib View
None ATI-450 View
None MK-2 View
None Bone metastasis View
None Breast Cancer View
None HR-positive/HER2-negative View
None Capecitabine View